Year: 2020
Type: review
Abstract: Diabetic cardiomyopathy (DCM) is a chronic complication of diabetes mellitus, characterized by abnormalities of myocardial structure and function. Researches on the models of type 1 and type 2 diabetes mellitus as well as the application of genetic engineering technology help in understanding the molecular mechanism of DCM. DCM has multiple hallmarks, including hyperglycemia, insulin resistance, increased free radical production, lipid peroxidation, mitochondrial dysfunction, endothelial dysfunction, and cell death. Essentially, cell death is considered to be the terminal pathway of cardiomyocytes during DCM. Morphologically, cell death can be classified into four different forms: apoptosis, autophagy, necrosis, and entosis. Apoptosis, as type I cell death, is the fastest form of cell death and mainly occurs depending on the caspase proteolytic cascade. Autophagy, as type II cell death, is a degradation process to remove damaged proteins, dysfunctional organelles and commences by the formation of autophagosome. Necrosis is type III cell death, which contains a great diversity of cell death processes, such as necroptosis and pyroptosis. Entosis is type IV cell death, displaying "cell-in-cell" cytological features and requires the engulfing cells to execute. There are also some other types of cell death such as ferroptosis, parthanatos, netotic cell death, lysosomal dependent cell death, alkaliptosis or oxeiptosis, which are possibly involved in DCM. Drugs or compounds targeting the signals involved in cell death have been used in clinics or experiments to treat DCM. This review briefly summarizes the mechanisms and implications of cell death in DCM, which is beneficial to improve the understanding of cell death in DCM and may propose novel and ideal strategies in future.
Source: Frontiers in Pharmacology
Authors: Yun Chen, Yuyun Hua, Xinshuai Li, Ishfaq Muhammad Arslan, Wei Zhang, Guoliang Meng
Institution: Nantong University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: diabetic cardiomyopathy, cell death, apoptosis, autophagy, necrosis, necroptosis, pyroptosis, entosis, ferroptosis, parthanatos, mitochondrial fission, caspase cascade, insulin resistance, hyperglycemia, mitochondrial dysfunction, endothelial dysfunction, lipid peroxidation, free radicals, cardiomyocytes
Open Access status: gold
Estimated APC paid: $2,950
Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Government of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Nantong University, Six Talent Peaks Project in Jiangsu Province, Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu Planned Projects for Postdoctoral Research Funds, Graduate Research and Innovation Projects of Jiangsu Province
Awards: G1091616984, G1122188366, G1227731638, G1279347373, G1345610955, G1461548854, G1716724144, G1917876622, 蛋白磷酸酶1调控CaMKⅡδ可变剪接在心肌缺血再灌注损伤中的作用及机制研究, G2224287627, G2481991077, G2507548254, G2608340182, G2891840721, G3053990812, G3505597412, G3814249319, G4124654127, G4628444863, G5079001295, G5262426388, G5656317958, G5987503815, G6316901400, G6363273897, G6418292419, G6419800772, SIRT3在硫化氢抗心肌肥大中的作用机制研究, G705756518, G7180466559, G7183958168, G7185284513, G7672934181, G7773875126, G7860251378, G7930910484, G8032387806, G8220863215, G8339699432, G8431356700, G8479791392, G8581502904, G8977490651, G960917204
OpenAlex ID: W3005113782
